ArticleOPEN ACCESS

Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study

Haematologica
DOI: 10.3324/haematol.2021.279564
17Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Marouf, A., Cottereau, A. S., Kanoun, S., Deschamps, P., Meignan, M., Franchi, P., … Deau, B. (2022, July 1). Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study. Haematologica. Ferrata Storti Foundation. https://doi.org/10.3324/haematol.2021.279564

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free